Skip to main content

Supportive Care in Cancer

Ausgabe 4/2015

Inhalt (36 Artikel)

Letter to the editor

The role of the OncPal deprescribing guideline in end-of-life care

Emily Reeve, Danijela Gnjidic, Sarah Hilmer

Original Article

Therapeutic and preventive antiemetic effect of aprepitant in Japanese patients with thoracic malignancies who truly need it

Sumiyo Ito, Ikuto Tsukiyama, Masahiko Ando, Masayo Katakami, Rie Hamanaka, Kenshi Kosaka, Ayako Matsubara, Masaki Nishimura, Hiroyuki Tanaka, Nobuhiro Asai, Norihito Yokoe, Ayumu Takahashi, Kenji Baba, Katsuhiko Matsuura, Etsuro Yamaguchi, Akihito Kubo

Original Article

Palliative performance scale and survival among outpatients with advanced cancer

Jeff Myers, Audrey Kim, Jamie Flanagan, Debbie Selby

Original Article

Assessment of radiation-induced xerostomia: validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients

Federica Pellegrino, Elena Groff, Luca Bastiani, Bruno Fattori, Guido Sotti

Original Article

Risk-reduction opportunities in breast cancer survivors: capitalizing on teachable moments

Krista Beth Highland, Alejandra Hurtado-de-Mendoza, Cassandra A. Stanton, Chiranjeev Dash, Vanessa B. Sheppard

Original Article

Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy

Deirdre R. Pachman, Breanna L. Weisbrod, Drew K. Seisler, Debra L. Barton, Kelliann C. Fee-Schroeder, Thomas J. Smith, Daniel H. Lachance, Heshan Liu, Randy A. Shelerud, Andrea L. Cheville, Charles L. Loprinzi

Original Article

Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers

Christine Miaskowski, Janine K. Cataldo, Christina R. Baggott, Claudia West, Laura B. Dunn, Anand Dhruva, John D. Merriman, Dale J. Langford, Kord M. Kober, Steven M. Paul, Bruce A. Cooper, Bradley E. Aouizerat

Original Article

Identifying clinical and support service resources and network practices for cancer patients and survivors in southern Puerto Rico

Eida M. Castro, Julio C. Jiménez, Gwendolyn Quinn, Myra García, Yesenia Colón, Axel Ramos, Thomas Brandon, Vani Simmons, Clement Gwede, Susan Vadaparampil, Cruz María Nazario

Original Article

The initial clinical interview—can it reduce cancer patients’ fear?

Sophie Elisabeth Groß, Anika Nitzsche, Tristan D. Gloede, Lena Ansmann, Richard Street, Holger Pfaff, Melanie Neumann, Markus Wirtz, Walter Baumann, Stephan Schmitz, Nicole Ernstmann

Original Article

Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation

Takahiro Takekiyo, Koichiro Dozono, Takayuki Mitsuishi, Yoshihiro Murayama, Ayako Maeda, Nobuaki Nakano, Ayumu Kubota, Masahito Tokunaga, Shogo Takeuchi, Yoshifusa Takatsuka, Atae Utsunomiya

Original Article

Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review

Christine Klimowicz White, Jessica Langholtz, Zackory T. Burns, Susan Kruse, Kimberly Sallee, David H. Henry

Original Article

A clinic-supported group exercise program for head and neck cancer survivors: managing cancer and treatment side effects to improve quality of life

Lauren C. Capozzi, Kevin R. Boldt, Harold Lau, Lisa Shirt, Barry Bultz, S. Nicole Culos-Reed

Original Article

C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms

Juan F. Combariza, Milton Lombana, Luis E. Pino, Marcos Arango

Original Article

Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer

Marcin Mardas, Małgorzata Jamka, Radosław Mądry, Jarosław Walkowiak, Marietta Krótkopad, Marta Stelmach-Mardas

Original Article

Worried together: a qualitative study of shared anxiety in patients with metastatic non-small cell lung cancer and their family caregivers

Ellen Hendriksen, Emma Williams, Nora Sporn, Joseph Greer, Alexandra DeGrange, Cheryl Koopman

Original Article

Association between the duration of palliative care service and survival in terminal cancer patients

Yong Joo Lee, Jung-Hwa Yang, Jung-Wook Lee, Johi Yoon, Jung-Ran Nah, Whan-Seok Choi, Chul-min Kim

Original Article

Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study

Lesley Stafford, Naomi Thomas, Elizabeth Foley, Fiona Judd, Penny Gibson, Angela Komiti, Jeremy Couper, Litza Kiropoulos

Original Article

The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer

Breffni Hannon, Nadia Swami, Ashley Pope, Gary Rodin, Elizabeth Dougherty, Ernie Mak, Subrata Banerjee, John Bryson, Julia Ridley, Camilla Zimmermann

Original Article

Effect of endurance for adverse drug reactions on the preference for aggressive treatments in cancer patients

Naomi Iihara, Takayuki Nishio, Tetsuko Goda, Hideaki Anzai, Masatoshi Kagawa, Hitoshi Houchi, Yutaka Kirino

Original Article

Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients

Luluel Khan, Michael Tjong, Hamid Raziee, Justin Lee, Darby Erler, Lee Chin, Ian Poon

Original Article

A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings

Paul Grossman, Diana Zwahlen, Jorg P. Halter, Jakob R. Passweg, Claudia Steiner, Alexander Kiss

Original Article

Sleep disturbance in cancer patients and caregivers who contact telephone-based help services

Bronwyn A. Morris, Frances P. Thorndike, Lee M. Ritterband, Nick Glozier, Jeff Dunn, Suzanne K. Chambers

Original Article

Agreement between accelerometer-assessed and self-reported physical activity and sedentary time in colon cancer survivors

Terry Boyle, Brigid M. Lynch, Kerry S. Courneya, Jeff K. Vallance

Original Article

Heterosexual couples and prostate cancer support groups: a gender relations analysis

John L. Oliffe, Lawrence W. Mróz, Joan L. Bottorff, Debbie E. Braybrook, Amanda Ward, Larry S. Goldenberg

Erratum

Erratum to: Heterosexual couples and prostate cancer support groups: a gender relations analysis

John L. Oliffe, Lawrence W. Mróz, Joan L. Bottorff, Debbie E. Braybrook, Amanda Ward, S. Larry Goldenberg

Open Access Original Article

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy

Yoshimasa Kosaka, Yoshiaki Rai, Norikazu Masuda, Toshimi Takano, Toshiaki Saeki, Seigo Nakamura, Ryutaro Shimazaki, Yoshinori Ito, Yutaka Tokuda, Kazuo Tamura

Review Article

Incorporating measures of sleep quality into cancer studies

Nancy S. Redeker, Wilfred R. Pigeon, Eilis A. Boudreau

Review Article

Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents

Donald L. Patrick, Charles S. Cleeland, Roger von Moos, Lesley Fallowfield, Rachel Wei, Katarina Öhrling, Yi Qian

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.